Premium
Encephalopathy with combined lithium‐risperidone administration
Author(s) -
Boora K.,
Xu J.,
Hyatt J.
Publication year - 2008
Publication title -
acta psychiatrica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.849
H-Index - 146
eISSN - 1600-0447
pISSN - 0001-690X
DOI - 10.1111/j.1600-0447.2008.01165.x
Subject(s) - risperidone , lithium (medication) , discontinuation , haloperidol , bipolar disorder , psychology , medicine , psychiatry , pediatrics , schizophrenia (object oriented programming) , dopamine
Objective: Lithium‐neuroleptics induced encephalopathy is a rare drug interaction. Here I am reporting a patient who developed reversible encepatholopathy with lithium‐risperidone combination. Method: A single case report. Result: A patient of bipolar disorder, who presented with manic symptoms with psychotic feature, started with a combination of lithium and risperidone. Within few days, the patient developed encepatholopathy, which reversed upon discontinuation of lithium and risperidone. Conclusion: Combining lithium and neuroleptic is useful in treatment of bipolar disorder. However, encepatholapthy can be anticipated to result when lithium is used with high potency anti‐psychotic such as haloperidol and risperidone and there are baseline EEG abnormalities.